Acute Myeloid Leukaemia (AML) is one of the deadliest blood cancers, with a 5-year survival rate of less than 25%. There has been no dramatic improvement in AML treatments since the 1970s, but this group of researchers has identified a druggable Achille’s Heel, specific to AML and other blood cancers.
Novel treatment for leukaemia
Novel targeted treatment for Acute Myeloid Leukaemia
If you click the button and fill out the form to be „matched“ with a technology, we will introduce you to the scientist / transfer manager of the respective research institution. In this way, you immediately have the chance to receive more detailed information and to start discussions about a possible joint project.